These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 35770414)
1. Arsenic Trioxide Restrains Lung Cancer Growth and Metastasis by Blocking the Calcineurin-NFAT Pathway by Upregulating DSCR1. Yang MH; Wang YS; Shi XQ; Zhao XW; Li B Curr Cancer Drug Targets; 2022; 22(10):854-864. PubMed ID: 35770414 [TBL] [Abstract][Full Text] [Related]
2. Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling. Zheng JC; Chang KJ; Jin YX; Zhao XW; Li B; Yang MH Med Sci Monit; 2019 Mar; 25():2228-2237. PubMed ID: 30913205 [TBL] [Abstract][Full Text] [Related]
3. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway. Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339 [TBL] [Abstract][Full Text] [Related]
4. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis. Shin J; Lee JC; Baek KH Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307 [TBL] [Abstract][Full Text] [Related]
5. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis? Yao YG; Duh EJ Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155 [TBL] [Abstract][Full Text] [Related]
6. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer. Yang MH; Chang KJ; Li B; Chen WS Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499 [TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide inhibits angiogenesis in vitro and in vivo by upregulating FoxO3a. Sun Z; Li M; Bai L; Fu J; Lu J; Wu M; Zhou C; Zhang Y; Wu Y Toxicol Lett; 2019 Oct; 315():1-8. PubMed ID: 31421153 [TBL] [Abstract][Full Text] [Related]
8. MDM2-mediated Inhibitory Effect of Arsenic Trioxide on Small Cell Lung Cancer Cell Line by Degrading Mutant p53. Wang YS; Yin JZ; Shi XQ; Zhao XW; Li B; Yang MH Anticancer Agents Med Chem; 2023; 23(16):1829-1837. PubMed ID: 37259217 [TBL] [Abstract][Full Text] [Related]
9. Notch pathway inhibition mediated by arsenic trioxide depletes tumor initiating cells in small cell lung cancer. Yang MH; Li B; Chang KJ Mol Biol Rep; 2022 Mar; 49(3):2245-2253. PubMed ID: 35028858 [TBL] [Abstract][Full Text] [Related]
10. The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases. Minami T; Jiang S; Schadler K; Suehiro J; Osawa T; Oike Y; Miura M; Naito M; Kodama T; Ryeom S Cell Rep; 2013 Aug; 4(4):709-23. PubMed ID: 23954784 [TBL] [Abstract][Full Text] [Related]
12. Depolarization of neural cells induces transcription of the Down syndrome critical region 1 isoform 4 via a calcineurin/nuclear factor of activated T cells-dependent pathway. Cano E; Canellada A; Minami T; Iglesias T; Redondo JM J Biol Chem; 2005 Aug; 280(33):29435-43. PubMed ID: 15975916 [TBL] [Abstract][Full Text] [Related]
13. Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer. Zhao X; Wang Q; Yang S; Chen C; Li X; Liu J; Zou Z; Cai D Eur J Pharmacol; 2016 Jun; 781():60-8. PubMed ID: 27041643 [TBL] [Abstract][Full Text] [Related]
14. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis. Gollogly LK; Ryeom SW; Yoon SS J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901 [TBL] [Abstract][Full Text] [Related]
15. Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Hesser BA; Liang XH; Camenisch G; Yang S; Lewin DA; Scheller R; Ferrara N; Gerber HP Blood; 2004 Jul; 104(1):149-58. PubMed ID: 15016650 [TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth. Ryeom S; Baek KH; Rioth MJ; Lynch RC; Zaslavsky A; Birsner A; Yoon SS; McKeon F Cancer Cell; 2008 May; 13(5):420-31. PubMed ID: 18455125 [TBL] [Abstract][Full Text] [Related]
17. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells. Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221 [TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis. Yang MH; Zang YS; Huang H; Chen K; Li B; Sun GY; Zhao XW Curr Cancer Drug Targets; 2014; 14(6):557-66. PubMed ID: 25088040 [TBL] [Abstract][Full Text] [Related]
20. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Liu B; Pan S; Dong X; Qiao H; Jiang H; Krissansen GW; Sun X Cancer Sci; 2006 Jul; 97(7):675-81. PubMed ID: 16827809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]